Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKansas City Heart Rhythm Research Foundation

About this trial

The purpose of the Long term Evaluation of Cardiac Arrhythmias after Transcatheter Aortic Valve Implantation (LOCATE) Registry is to perform long-term ambulatory monitoring of patients with severe aortic stenosis who undergo trans-catheter aortic valve implantation (TAVI) and develop new onset conduction system abnormalities post-procedure that do not require urgent permanent pacemaker (PPM) implantation. The primary objectives of this study are to assess the incidence of late onset heart block necessitating PPM implantation and to evaluate the incidence of new onset atrial fibrillation (AF) following TAVI. This study aims to provide valuable insights into the long-term cardiac health of TAVI patients and inform the development of improved treatment strategies for aortic stenosis patients with conduction system abnormalities.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

New left bundle branch block (QRS >120ms)

New first degree AV block (PR>200ms) or worsening of pre-existing first-degree AV block by >30ms

New right bundle branch block (QRS>120ms)

Intra-procedural 2:1 or higher-grade AV block with spontaneous improvement within 24 hours

Disqualifiers

Patients with high grade or complete AV block post TAVI needing urgent pacemakers

Patient with existing cardiac implantable electronic devices (CIEDs)

Patients having a particular medical condition that dictates that they cannot tolerate subcutaneous, chronically-inserted device

Patient is currently pregnant as evidenced by urine positive Beta-HCG. (Urine Beta human chorionic gonadotropin (HCG) will be checked in all females of the reproductive age group).

Trial population

Patients who have undergone Boston Scientific Loop Recorder (LUX-Dx PMA# K193473) as standard of care for arrhyhtmia monitoring after TAVI procedure will have the ILR monitored monthly by the electrophysiology team. All alerts will be reviewed and discussed with the implanting physician for further management. Patients will be followed for up to 12 months.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • TAVR Procedure and implantation of Boston Scientific Loop Recorder (LUX-Dx PMA# K193473)

    Device

    No intervention will be done as part of this prospective registry. Implantation of Boston Scientific Loop Recorder (LUX-Dx) will be performed regardless of this research and outside this research protocol per standard of care

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Transcatheter aortic valve replacement (TAVR) with Boston Scientific Loop Recorder1 intervention

Trial outcomes

Primary outcomes

1

Incidence of brady arrhythmias

Incidence of significant brady arrhythmias (2:1 or higher-grade Atrioventricular block (AV) block) requiring pacemaker implantation post TAVI in patients with evidence of conduction system injury following TAVI

Time frame
12 Months
2

Predictors of development of late onset heart block needing pacing

Evaluate predictors of development of late onset (\>30 days) heart block needing pacing

Time frame
12 Months
3

New onset Atrial Fibrillation

Assess the incidence of new onset atrial fibrillation post TAVI

Time frame
12 Months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.